The EPAD team has published a new paper entitled “Cognitive Dispersion is not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Results from the European Prevention of Alzheimer’s Dementia (EPAD) v500.0 Cohort” in the journal of Alzheimer’s disease. Abstract: Background: Cognitive dispersion, variation in performance across cognitive domains, is posited as a non-invasive and cost-effective…
DetailsThe European Research Council has awarded an Early Career Research (ERC) starting grant to the neurologist Marc Suárez-Calvet, MD, PhD, who will use data from the EPAD Longitudinal Cohort Study for his new project entitled “Identification of age-related Human Blood factors as a therapeutic target for Alzheimer’s disease” (acronym: HeBe). The overall aim of the…
DetailsWe are writing to you with the latest news of the EPAD project. What will the world be like once the COVID-19 pandemic is over? We can all speculate, formulate, hypothesise, hope and fear – we will all have our personal crystal balls – some cloudy, some clearer, some ignored and some stared into constantly…
DetailsThe past years were very productive and efficient for the EPAD project. In this piece, we wanted to reflect back on some of the important advances and major achievements made by each Work Package (WP). WP1 (Scientific challenges) Creation of 5 Scientific Advisory Groups (SAGs) – Clinical and Cognitive Outcomes, Fluid Biomarkers, Genetics, Imaging and…
DetailsCould you tell us a bit about you? I am an expert psychologist with a special interest in cognition and its measurement. I have recently been appointed Chief Science Officer at Neurotrack and am Principal Consultant at Metis Cognition, a psychology practice established to advise with the selection and successful integration of cognitive testing into…
DetailsWe are pleased to inform you that the 2020 William Farr Medal of the Worshipful Society of Apothecaries was awarded to our Project Co-coordinator Craig Ritchie in recognition of the substantial impact made at a global level on the wellbeing of older people through leadership of dementia prevention research and service innovation, merging expertise in…
DetailsThe SPEAR (Study of Participant Experience of Alzheimer’s disease Research) study was carried out as part of EPAD’s Work Package on the Ethical, Legal and Social Implications of the project (ELSI). In the early stages of EPAD, the ELSI team pointed to the extent and intensity of tests and measurements deemed necessary to provide a…
DetailsLucy Stirland has been awarded the 2020 Porto Research Award from the European Federation of Psychiatric Trainees (EFPT) for her paper using EPAD V500.0 data, published last year in the Journal of Alzheimer’s Disease. The aims of this award are to encourage psychiatric trainees to conduct research and contribute to the engagement of psychiatry trainees…
DetailsCould you tell us a bit about you and your work? After studying Cognitive Neuroscience and Neuropsychology in Rome I started my PhD in Amsterdam as part of the EPAD project. My work within EPAD consists in analysing neuroimaging outcomes to first create a shared and publicly available dataset for internal and external researchers and…
DetailsThe European Prevention of Alzheimer’s Dementia (EPAD) project is very pleased to announce the external release of its second wave of data including the baseline data from the first 1.500 research participants (V1500.0). “This most recent and substantial data release from the EPAD cohort will undoubtedly have a major impact on our understanding of Alzheimer’s…
Details
